I-Pepsinogen I Pepsinogen II kunye ne-Gastrin-17 Combo rapid test kit
Ikhithi yokuxilonga yePepsinogen I/Pepsinogen II/Gastrin-17
Indlela yokusebenza: uvavanyo lwe-fluorescence immunochromatographic
Ulwazi lwemveliso
| Inombolo yoMzekelo | G17/PGI/PGII | Ukupakisha | Iimvavanyo ezingama-25/ikhithi, iikhithi ezingama-30/i-CTN |
| Igama | Ikhithi yokuxilonga yePepsinogen I/Pepsinogen II/Gastrin-17 | Ukuhlelwa kwezixhobo | Iklasi yesiBini |
| Iimbonakalo | Uvakalelo oluphezulu, Ukusebenza lula | Isatifikethi | I-CE/ ISO13485 |
| Ukuchaneka | > 99% | Beka ubomi kwishelufa | Iminyaka emibini |
| Indlela yokusebenza | uvavanyo lwe-fluorescence immunochromatographic | Inkonzo ye-OEM/ODM | Iyafumaneka |
UKUSETYENZISWA OKUJOLISWEYO
Le khithi iyasebenza ekufumaneni ubungakanani be-Pepsinogen I (PGI) kunye ne-Pepsinogen II kwi-in vitro
(PGII) kunye neGastrin 17 kwiisampuli ze-serum/plasma/zegazi elipheleleyo lomntu, ukuvavanya iseli ye-gastric oxyntic gland
umsebenzi, isilonda se-mucosa yesisu kunye ne-atrophic gastritis. Le khithi inika kuphela iziphumo zovavanyo lwePepsinogen I
(PGI), iPepsinogen II (PGII) kunye neGastrin 17. Iziphumo ezifunyenweyo kufuneka zihlalutywe kunye nezinye iindlela zonyango.
Ulwazi. Kufuneka lusetyenziswe kuphela ziingcali zezempilo.
Inkqubo yovavanyo
| 1 | Ngaphambi kokusebenzisa i-reagent, funda ngononophelo iphakheji kwaye uqhelane neenkqubo zokusebenza. |
| 2 | Khetha imo yovavanyo eqhelekileyo ye-WIZ-A101 portable immune analyzer. |
| 3 | Vula iphakheji ye-reagent yebhegi yefoyile ye-aluminiyam uze ukhuphe isixhobo sovavanyo. |
| 4 | Faka isixhobo sovavanyo ngokuthe tye kwindawo yokuhlaziya umzimba. |
| 5 | Kwiphepha lasekhaya le-interface yokusebenza ye-immune analyzer, cofa u-“Standard” ukuze ungene kwi-interface yovavanyo |
| 6 | Cofa u-“QC Scan” ukuze uskene ikhowudi ye-QR ngaphakathi kwekhithi; iiparameter ezinxulumene nekhithi yokufaka kwisixhobo kunye khetha uhlobo lwesampulu. Qaphela: Inani ngalinye lebhetshi yekhithi kufuneka liskeniwe kube kanye. Ukuba inani lebhetshi liskeniwe, ngoko ke tsiba eli nyathelo. |
| 7 | Jonga ukuhambelana kwe "Igama leMveliso", "Inombolo yeBatch" njl. Kwi-interface yovavanyo kunye nolwazi olukwikhithi ileyibhile. |
| 8 | Emva kokuba ulwazi luqinisekisiwe, khupha iisampulu ze-diluents, yongeza i-80µL ye-serum/plasma/igazi elipheleleyo. isampuli, kwaye udibanise ngokwaneleyo. |
| 9 | Yongeza i-80µL yesisombululo esixutyiweyo esingentla kumngxuma wesampulu yesixhobo sovavanyo. |
| 10 | Emva kokongeza isampuli epheleleyo, cofa u-“Timing” kwaye ixesha eliseleyo lovavanyo liya kuboniswa ngokuzenzekelayo kwi ujongano. |
| 11 | I-immune analyzer izakugqiba uvavanyo kunye nohlalutyo ngokuzenzekelayo xa ixesha lovavanyo lifikile. |
| 12 | Ukubalwa kwesiphumo kunye nokuboniswa Emva kokuba uvavanyo oluqhutywa yi-immune analyzer lugqityiwe, iziphumo zovavanyo ziya kuboniswa kwi-interface yovavanyo okanye zinokujongwa ngokusebenzisa "Imbali" kwiphepha lasekhaya le-interface yokusebenza. |
Ukusebenza kweKlinikhi
Ukusebenza kovavanyo lweklinikhi kwemveliso kuvavanywa ngokuqokelela iisampuli zeklinikhi ezingama-200. Sebenzisa ikhithi ethengiswayo ye-enzyme linked immunosorbent assay njenge-reagent yokulawula. Thelekisa iziphumo zovavanyo lwe-PGI. Sebenzisa i-linearity regression ukuphanda ukuthelekiswa kwazo. Ii-coefficients zokuhambelana kweemvavanyo ezimbini yi-y = 0.964X + 10.382 kunye ne-R=0.9763 ngokwahlukeneyo. Thelekisa iziphumo zovavanyo lwe-PGII. Sebenzisa i-linearity regression ukuphanda ukuthelekiswa kwazo. Ii-coefficients zokuhambelana kweemvavanyo ezimbini yi-y = 1.002X + 0.025 kunye ne-R=0.9848 ngokwahlukeneyo. Thelekisa iziphumo zovavanyo lwe-G-17. Sebenzisa i-linearity regression ukuphanda ukuthelekiswa kwazo. Ii-coefficients zokuhambelana kweemvavanyo ezimbini yi-y = 0.983X + 0.079 kunye ne-R=0.9864 ngokwahlukeneyo.
Ungathanda kwakhona:















